Overview
Pulmonary nocardiosis is a rare opportunistic infection caused by Nocardia species, often challenging to diagnose due to its imaging similarities to malignancy and low sensitivity of conventional cultures 1. It can affect both immunocompetent and immunocompromised individuals, with varying presentations and severity 12.Diagnosis
Imaging findings: Often mistaken for lung cancer due to nodular or cavitary lesions 1.
Conventional cultures: Low sensitivity, often requiring alternative diagnostic methods 1.
Metagenomic next-generation sequencing (mNGS): Provides definitive diagnosis when conventional methods are inconclusive 1.
Modified acid-fast staining: Useful for identifying Nocardia organisms in sputum 2.
CT scans: Essential for detailed assessment of lung lesions and complications like SVC syndrome 2.Management
First-line antibiotics: Piperacillin-tazobactam or ceftriaxone are commonly initiated empirically 1.
Adjunctive treatments: Inhaled ipratropium bromide and expectorants to manage symptoms 1.
Specific antibiotic adjustment: Based on culture and sensitivity results, tailored therapy with agents like ceftriaxone may be continued 1.
Duration: Treatment typically prolonged, often lasting several months to ensure eradication 12.Special Populations
Immunocompromised (HIV-infected): Rapid progression possible; close monitoring and early aggressive treatment crucial 2.
Superior vena cava (SVC) syndrome: Rare complication noted in HIV patients; requires multidisciplinary management 2.Key Recommendations
Utilize metagenomic next-generation sequencing (mNGS) when conventional cultures are negative or inconclusive for definitive diagnosis of pulmonary nocardiosis (Evidence: Moderate 1).
Initiate empirical antibiotic therapy with broad-spectrum agents like piperacillin-tazobactam in suspected cases, adjusting based on culture results (Evidence: Moderate 1).
Closely monitor immunocompromised patients, particularly those with HIV, for rapid disease progression and complications such as SVC syndrome (Evidence: Weak 2).References
1 Hu H, Cai D, Li J, Wang K. Pulmonary infection by . Frontiers in cellular and infection microbiology 2026. link
2 Kiatsuranon P, Suwanpimolkul G. Pulmonary Nocardiosis with Superior Vena Cava Syndrome in a HIV-Infected Patient: a Rare Case Report in the World. Japanese journal of infectious diseases 2021. link